TNF and non-Hodgkin lymphoma: While many recent larger scale investigations of TNF-alpha inhibitors in RA specifically have not shown a consistent association, there may be an increased risk of nonmelanomatous skin cancer and non-Hodgkin lymphoma (particularly follicular lymphoma) in patients older than 65 years [5, 13–15].